top of page


Press releases


Sachi's Nanoligomer treatments and nearly 600 patient-based brain Organoids fly on NASA's Space X CRS 31 Mission
Sachi Bio plans to utilize brain organoids in microgravity, which is the state of apparent weightlessness experienced during free fall or...
Nov 4, 2024


Sachi Bio’s New Treatment Featured by Multiple Media Outlets: A “game-changing tool” in fight against Alzheimer’s, Dementia, and Aging
KEYWORDS: Alzheimer’s, aging, dementia, treatment, Nanoligomer Read more at: Denver Post Colorado State University Press release DENVER -...
Sep 6, 2024


Age-reversing effects of Sachi's Drug Molecule published in the Journal of Neuroinflammation
As the brain gets older or in conditions like Alzheimer’s, inflammation becomes a major problem that damages brain cells, leading to...
Sep 2, 2024


Oral formulation of Nanoligomer treatments is Protective in Autoimmune (Colitis) Disease: Findings Published in ACS Pharmacology & Translational Science
Autoimmune and autoinflammatory diseases affect millions of people in the U.S., and among these, inflammatory bowel diseases (IBD) like...
Aug 31, 2024


The Future is Here: Sachi Bio Advances Space-based Drug Discovery
In the realm of pharmaceuticals, the pursuit of innovation knows no bounds. Scientists and researchers constantly strive to leverage...
Aug 15, 2024


Sachi Bio's Nanoligomers Reduce Space-induced Disease Pathology: Findings Published in ACS Chemical Neuroscience
Space travel has long fascinated humanity, but it also poses significant health risks, particularly to the brain and muscles. The...
Jul 31, 2024


Sachi Bio wins NASA Phase IIE and III contracts to Develop Neuroprotective Countermeasures for Long-term Space travel
Sachi Bio won Phase IIE and Phase III contracts from the NASA Human Research Program to continue advancement of the Neurotherapeutic...
Apr 15, 2024

Investigational New Drug (IND)-enabling Studies for Sachi Bio's lead molecule
Sachi Bio's lead program NI112 shows excellent Safety-Toxicity, brain-delivery, and biodistribution profile in Investigational New Drug...
Mar 31, 2024


Subscribe to Our Newsletter
bottom of page